Treatment optimisation in drug development : study : Panel for the Future of Science and Technology
Treatment optimisation in drug development : study : Panel for the Future of Science and Technology / EPRS - European Parliamentary Research Service
.-- Brussels : European Union, March 2020
.-- V, 70 p. ; 1 documento PDF
Bibliografía: p. 66-70
The development of novel health technologies is a complex and costly process that follows an extensive set of regulatory guidelines and legal provisions intended to ensure that the treatments reach the patients that need them in a highly controlled and standardised manner
Reproduction and translation for non-commercial purposes are authorised, provided the source is acknowledged and the European Parliament is given prior notice and sent a copy.
978-92-846-6037-7
10.2861/114406 doi
Sanidad digital
treatment optimisation
clinical drug
treatment
patient
public health
industry
Parlamento Europeo. Dirección General de Servicios de Estudios Parlamentarios
Bibliografía: p. 66-70
The development of novel health technologies is a complex and costly process that follows an extensive set of regulatory guidelines and legal provisions intended to ensure that the treatments reach the patients that need them in a highly controlled and standardised manner
Reproduction and translation for non-commercial purposes are authorised, provided the source is acknowledged and the European Parliament is given prior notice and sent a copy.
978-92-846-6037-7
10.2861/114406 doi
Sanidad digital
treatment optimisation
clinical drug
treatment
patient
public health
industry
Parlamento Europeo. Dirección General de Servicios de Estudios Parlamentarios